Literature DB >> 24199016

Esophageal dysmotility in gillespie syndrome.

Bruna Dell'acqua Cassão1, Daniel Tavares de Rezende, Luciana C Silva, Fernando A M Herbella.   

Abstract

Entities:  

Year:  2013        PMID: 24199016      PMCID: PMC3816190          DOI: 10.5056/jnm.2013.19.4.538

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


× No keyword cloud information.
A 16-year-old girl presented with dysphagia and heartburn for 10 years. She was diagnosed with Gillespie syndrome at the age of 1 year. Neurologic findings were represented by bilateral aniridia, strabismus, ataxia and cognitive impairment. Karyotype was normal (46, XX). The upper digestive endoscopy disclosed an esophageal dilation and a 5 cm sized Barrett's esophagus confirmed by biopsy. High-resolution manometry showed aperistalsis and a non-detectable lower esophageal sphincter due to severe hypotonia (Figure), corresponding to absent peristalsis on the Chicago classification.1 Ambulatory 24 hours pH monitoring disclosed a pathological acid reflux (total % time pH < 4: 36%, DeMeester score = 149).
Figure

High-resolution manometry showing aperistalsis and a non-detected lower esophageal sphincter due to severe hypotonia.

Gillespie syndrome is a very rare disease described firstly in 1965. It is defined by the triad of cerebellar ataxia, aniridia and mental deficiency.2 Associated manifestations have been infrequently described.3,4 However, esophageal involvement has never been reported. Although the presented association between Gillespie syndrome and esophageal dysmotility may be incidental, there is also a possibility that esophageal dysmotility could be a true sign of Gillespie syndrome. We consider Frizzled 4 gene could be related with both conditions. Frizzled 4 gene is expressed in cerebellar Purkinje cells, esophageal skeletal muscle and cochlear inner hair cells and the targeted deletion of this gene in rats exhibited distinct defects such as absence of a skeletal muscle sheath around the lower esophagus associated with progressive esophageal distension and dysfunction.5
  5 in total

1.  ANIRIDIA, CEREBELLAR ATAXIA, AND OLIGOPHRENIA IN SIBLINGS.

Authors:  F D GILLESPIE
Journal:  Arch Ophthalmol       Date:  1965-03

Review 2.  Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography.

Authors:  A J Bredenoord; M Fox; P J Kahrilas; J E Pandolfino; W Schwizer; A J P M Smout
Journal:  Neurogastroenterol Motil       Date:  2012-03       Impact factor: 3.598

3.  Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene.

Authors:  Y Wang; D Huso; H Cahill; D Ryugo; J Nathans
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

4.  Partial aniridia, cerebellar ataxia, and mental deficiency (Gillespie syndrome) in two brothers.

Authors:  E O Wittig; C A Moreira; N Freire-Maia; A M Vianna-Morgante
Journal:  Am J Med Genet       Date:  1988-07

5.  Gillespie syndrome: additional findings and parental consanguinity.

Authors:  Daniela Varela Luquetti; Ruy Pires Oliveira-Sobrinho; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Ophthalmic Genet       Date:  2007-06       Impact factor: 1.803

  5 in total
  2 in total

1.  Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome.

Authors:  Sylvie Gerber; Kamil J Alzayady; Lydie Burglen; Dominique Brémond-Gignac; Valentina Marchesin; Olivier Roche; Marlène Rio; Benoit Funalot; Raphaël Calmon; Alexandra Durr; Vera Lucia Gil-da-Silva-Lopes; Maria Fernanda Ribeiro Bittar; Christophe Orssaud; Bénédicte Héron; Edward Ayoub; Patrick Berquin; Nadia Bahi-Buisson; Christine Bole; Cécile Masson; Arnold Munnich; Matias Simons; Marion Delous; Helene Dollfus; Nathalie Boddaert; Stanislas Lyonnet; Josseline Kaplan; Patrick Calvas; David I Yule; Jean-Michel Rozet; Lucas Fares Taie
Journal:  Am J Hum Genet       Date:  2016-04-21       Impact factor: 11.025

2.  Genetic Analysis of 'PAX6-Negative' Individuals with Aniridia or Gillespie Syndrome.

Authors:  Morad Ansari; Jacqueline Rainger; Isabel M Hanson; Kathleen A Williamson; Freddie Sharkey; Louise Harewood; Angela Sandilands; Jill Clayton-Smith; Helene Dollfus; Pierre Bitoun; Francoise Meire; Judy Fantes; Brunella Franco; Birgit Lorenz; David S Taylor; Fiona Stewart; Colin E Willoughby; Meriel McEntagart; Peng Tee Khaw; Carol Clericuzio; Lionel Van Maldergem; Denise Williams; Ruth Newbury-Ecob; Elias I Traboulsi; Eduardo D Silva; Mukhlis M Madlom; David R Goudie; Brian W Fleck; Dagmar Wieczorek; Juergen Kohlhase; Alice D McTrusty; Carol Gardiner; Christopher Yale; Anthony T Moore; Isabelle Russell-Eggitt; Lily Islam; Melissa Lees; Philip L Beales; Stephen J Tuft; Juan B Solano; Miranda Splitt; Jens Michael Hertz; Trine E Prescott; Deborah J Shears; Ken K Nischal; Martine Doco-Fenzy; Fabienne Prieur; I Karen Temple; Katherine L Lachlan; Giuseppe Damante; Danny A Morrison; Veronica van Heyningen; David R FitzPatrick
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.